tirzepatide cas (LY3298176) sodium | GIP/GLP-1 Receptor Agonist | 2023788-19-2 (free base) Tirzepatide CAS 2023788-19-2 Factory hot
Description
Among participants with chronic kidney disease, tirzepatide slowed the decline in estimated glomerular filtration rate (eGFR) more effectively than dulaglutide (treatment difference: 3.54 mL/min/1.73 m
dosing is individualized
Metabolic Support The medication may also help regulate blood glucose levels and support metabolic health
In that case, youd take your dose on Saturday as usual, then again on Wednesday (since more than 48 hours have passed)
